1. Home
  2. SANW vs GLYC Comparison

SANW vs GLYC Comparison

Compare SANW & GLYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANW
  • GLYC
  • Stock Information
  • Founded
  • SANW 1980
  • GLYC 2003
  • Country
  • SANW United States
  • GLYC United States
  • Employees
  • SANW N/A
  • GLYC N/A
  • Industry
  • SANW Farming/Seeds/Milling
  • GLYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SANW Consumer Staples
  • GLYC Health Care
  • Exchange
  • SANW Nasdaq
  • GLYC Nasdaq
  • Market Cap
  • SANW 18.8M
  • GLYC 15.9M
  • IPO Year
  • SANW 2010
  • GLYC 2014
  • Fundamental
  • Price
  • SANW $4.75
  • GLYC $0.22
  • Analyst Decision
  • SANW Strong Buy
  • GLYC Hold
  • Analyst Count
  • SANW 1
  • GLYC 3
  • Target Price
  • SANW $35.00
  • GLYC N/A
  • AVG Volume (30 Days)
  • SANW 6.1K
  • GLYC 286.7K
  • Earning Date
  • SANW 05-13-2025
  • GLYC 05-08-2025
  • Dividend Yield
  • SANW N/A
  • GLYC N/A
  • EPS Growth
  • SANW N/A
  • GLYC N/A
  • EPS
  • SANW N/A
  • GLYC N/A
  • Revenue
  • SANW $54,809,365.00
  • GLYC N/A
  • Revenue This Year
  • SANW N/A
  • GLYC N/A
  • Revenue Next Year
  • SANW $14.25
  • GLYC N/A
  • P/E Ratio
  • SANW N/A
  • GLYC N/A
  • Revenue Growth
  • SANW N/A
  • GLYC N/A
  • 52 Week Low
  • SANW $2.10
  • GLYC $0.14
  • 52 Week High
  • SANW $11.60
  • GLYC $2.36
  • Technical
  • Relative Strength Index (RSI)
  • SANW 29.88
  • GLYC 47.98
  • Support Level
  • SANW $4.55
  • GLYC $0.17
  • Resistance Level
  • SANW $5.60
  • GLYC $0.22
  • Average True Range (ATR)
  • SANW 0.45
  • GLYC 0.02
  • MACD
  • SANW -0.11
  • GLYC 0.00
  • Stochastic Oscillator
  • SANW 21.54
  • GLYC 83.33

About SANW S&W Seed Company (NV)

S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.

About GLYC GlycoMimetics Inc.

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

Share on Social Networks: